The 20 Best Pleuropulmonary Blastoma Doctors near Edmonds, WA

More people survive cancer now than ever before. I see my role as being a strong advocate for my patients, fully informing them of their options and supporting them throughout their treatment programs. Dr. Fer is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

"At the age of three, Dr. Johnston knew exactly what she was going to do as an adult, and she never changed her mind. She was going to be a doctor. During her third year of residency, she encountered outpatient medical oncology. Dr. Johnston is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Johnston draws a special satisfaction from working with a team of compassionate professionals, all dedicated solely to the care of cancer patients. ""Everything here is focused on the patient and on one specialty - cancer care. It's set up to be more efficient, more personalized yet state-of-the art. I know my patients will notice that everything is geared towards them. I like the complexity of oncology, the challenge and the fact that you're bringing the full scope of your medical skills in to caring for your patient as well as their families."" Dr. Johnston enjoys cooking, running, swimming, biking, skiing and spending time with her three, young adult daughters.". Dr. Johnston is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Colorectal Cancer.

Dr. Takamiya is an experienced radiation oncologist that has been an integral part of the Swedish Cancer Institute since 2004. Serving as the medical director of Radiation Oncology at Edmonds since 2005, he has been an integral part of the Edmonds Cancer Committee, holding positions such as a physician member, cancer liaison physician and chair since 2008. Dr. Takamiya joined the Seattle Prostate Institute at Swedish, which pioneered LDR prostate brachytherapy. There, he was the director education, training other physicians across the globe. He is an expert in prostate brachytherapy, as well as high risk prostate cancer. He has brought new oncologic therapies to Swedish Edmonds, including novel radiopharmaceuticals. Areas of clinical interest include brain tumors, head and neck cancer, lung, breast, and GI malignancies. Recognized for his exceptional dedication to his patients and his field, Dr. Takamiya is a multiple recipient of the Seattle Top Doctor Award, and most recently, he was honored with the Seattle Met 2023 Top Doc Award. With an unwavering commitment to excellent patient care, Dr. Takamiya delivers personalized cancer care right in the heart of Edmonds. Through the Swedish Cancer Institute, patients not only received top-tier treatment but also gain access to advanced treatments therapies, comprehensive support, and the expertise of a world-class cancer institute. This ensures that patients receive the best care possible while being close to home. This is very important to Dr. Takamiya, who himself is a member of this community. Dr. Takamiya is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

Martin Palmer is a Hematologist in Edmonds, Washington. Dr. Palmer is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma.

Meng Zhao, MD, PhD, joined Providence Swedish in July 2020. She received her medical degree from the Tongji University School of Medicine in Shanghai, China. Dr. Zhao completed an Internal Medicine Residency at the University of Texas Southwestern Medical Center, and then went on to study Oncology and Hematology at The Ohio State University Comprehensive Cancer Center and Wexner Medical Center in Columbus, OH. She is board certified by the American Board of Medical Oncology, and the American Board of Hematology. She is also a member of the American Society of Clinical Oncology. She earned a PhD in Cell and Molecular Biology at the University of Texas at Austin in Austin, TX. Philosophy of Care: Dr. Zhao focuses on personalized care and shared decision-making. She engages in open dialogues with patients and their families to discuss diagnoses and treatment options. Dr. Zhao blends clinical excellence with compassion and empathy. Her mission is to enhance the outcomes and quality of life for cancer patients and their families throughout their journey. Dr. Zhao, a skilled clinical researcher, previously held the role of clinical research director and principal investigator for diverse clinical trials. Now, in Swedish Cancer Institute, she continues her cancer research journey, benefiting patients with a robust clinical trials program and cutting-edge treatments. Dr. Zhao is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. Her top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Pleuropulmonary Blastoma, Neonatal Onset Multisystem Inflammatory Disease, and Breast Cancer.

Dr. Lopez believes in providing holistic care to his patients which includes the treatment of their medical diagnosis, as well as their social and emotional needs. Dr. Lopez is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Angiosarcoma.

"Dr. Montgomery is a native of the greater Seattle area: she was born and raised in Issaquah and went to Whitman College for her undergraduate studies. She decided to pursue a medical degree after a family member was diagnosed with cancer. She received her medical education at the University of Washington and was drawn early on to medical oncology as a subspecialty. ""In oncology clinic, seeing the quality of the patient-doctor interaction, with its level of intensity, transparency and degree of compassion really impacted me, both as a person and as a physician."" Having seen both sides of cancer care, both as a physician and as a family member of a patient, Dr. Montgomery understands the importance of patient-centered care and the team approach. ""Providing excellent, state-of-the-art, individualized care really does 'take a village:' a multi-disciplinary team of providers, along with the patient him/herself, are paramount to providing the best possible care."" In her free time, Dr. Montgomery enjoys staying active, outdoor adventures and spending time with family and friends.". Dr. Montgomery is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Gastrointestinal Stromal Tumor, and Polycythemia Vera.

Dr. Fang is a distinguished radiation oncologist with expertise in treating various cancers including breast, brain, lung, and more. She completed her radiation oncology residency at the University of Washington and a fellowship at MD Anderson Cancer Center. With over a decade of experience at the University of Washington and Fred Hutch Cancer Center, she joined the Swedish Cancer Institute in 2022. As an Associate Professor at the University of Washington, Dr. Fang significantly contributed to multi-institutional clinical trials, trained residents, and served on key committees. Her innovative work in proton therapy for breast cancer has earned her national recognition. Known for her compassionate care, Dr. Fang adopts an evidence-based, personalized approach to ensure her patients receive the highest quality of care. She emphasizes patient understanding and empowerment, helping them make informed decisions. Dr. Fang’s dedication and patient-centric approach make her a valued collaborator in her patients’ healthcare journeys. Dr. Fang is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Glioma, and Brain Tumor.

Dr. Norman is board-certified in Internal Medicine, Hematology and Oncology. With twenty years of practice experience, Dr. Norman is well prepared to provide your care. He is person centered-providing the best care based upon national guidelines, but tailored to your specific needs. Dr. Norman is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Anal Cancer, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Small Cell Lung Cancer (SCLC).

Douglas Wood is a Cardiologist and a Pulmonary Medicine provider in Seattle, Washington. Dr. Wood is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Lung Cancer, Lung Nodules, Pleuropulmonary Blastoma, Endoscopy, and Tissue Biopsy.

Misho Hubka, MD, is a board-certified thoracic surgeon. His special medical interests include Robotic and Video-Assisted Thoracoscopic Surgery (VATS), lung cancer surgery, esophageal cancer surgery, and complex surgery for benign and malignant disease of the lung, chest wall, esophagus and mediastinum.Dr. Hubka is a member of the Society of Thoracic Surgeons, STS Patient Safety Workforce and Western Thoracic Surgical Association. He was named a Top Doctor by Seattle Met Magazine in 2017, 2018 and 2019. Dr. Hubka is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Hiatal Hernia, Hernia, Neuroendocrine Tumor, Gastrostomy, and Endoscopy.

Cancer is a terrible disease—often one of the most frightening and uncertain experiences a person can face. My philosophy is to approach every patient with a blend of deep empathy and evidence-based treatment options, empowering them to make informed decisions that align with their values, needs, and goals. I believe that compassionate care and scientific rigor form the foundation of meaningful, personalized cancer care. Dr. Santana is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Dr. Devarakonda trained and worked on faculty at the Washington University in St. Louis before joining Swedish. His research is focused on understanding cancers utilizing sequencing technologies. He has an excellent understanding of the latest advances in thoracic oncology (lung cancer, thymic malignancies, mesothelioma). He believes in providing the same level of care for his patients that he expects for his own family. His list of peer-reviewed scientific publications can be accessed here https://pubmed.ncbi.nlm.nih.gov/?term=Devarakonda+S&cauthor_id=34591593. Dr. Devarakonda is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Nerve Decompression, and Endoscopy.

Dr. Landis is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He truly enjoys the challenge of caring for cancer patients. A diagnosis of cancer can be overwhelming for a patient and their family. From the beginning he will review the diagnosis in detail, the treatment options, and the potential results of each option, including possible side effects. Dr. Landis enjoys seeing his patients over time, during the course of treatment, and in follow-up. Often it takes some time to understand the patients priorities and wishes. As a physician, he believes in prioritizing the patients quality of life and listening to understand their desires and incorporate this into an individualized treatment plan. He strives to provide the best possible care to all of his patients. Dr. Landis is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Nasopharyngeal Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor.

Douglas Lee is an Oncologist in Edmonds, Washington. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Edmond Marzbani is an Oncologist in Seattle, Washington. Dr. Marzbani is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor.

Paul Martin is a Hematologist in Seattle, Washington. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Autoimmune Hemolytic Anemia, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

Jing Zeng is a Radiation Oncologist in Seattle, Washington. Dr. Zeng is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. Her top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Metastatic Pleural Tumor. Dr. Zeng is currently accepting new patients.

Eric Taylor is a Radiation Oncologist in Kirkland, Washington. Dr. Taylor is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Endometrial Stromal Sarcoma. Dr. Taylor is currently accepting new patients.